Estás a punto de abandonar la web de ISDIN para ir a un espacio privado para profesionales de la salud. ¿Quieres continuar?
Itragerm 50 mg is the first low-dose itraconazole on the market, and thanks to its SUBA drug administration technology, it improves the bioavailability of its soluble substances, increasing the drug’s absorption and reliability1.
The SUBA technology soluble microparticles contained in Itragerm 50 mg improve bioavailability. Thanks to this innovative new technology, Itragerm 50 mg produces the same therapeutic effect as conventional 100 mg itraconazole at lower doses.
Itragerm 50 mg
Soluble microparticles
Itraconazole 100 mg
Insoluble crystals
Itragerm 50 mg
Soluble microparticles
Itraconazole 100 mg
Insoluble crystals
Thanks to SUBA technology, Itragerm 50 mg improves the plasma bioavailability of itraconazole by 80-90% versus 55% of the conventional formulation.
In Itragerm, absorption is not affected by the gastric pH, so patients who are taking proton-pump inhibitors can now continue to do so.
The SUBA technology used in Itragerm 50 mg improves itraconazole bioavailability in plasma to 80-90%, compared to 55% for conventional formulations.
Itragerm absorption is not affected by gastric pH. This means that, from now on, patients taking proton pump inhibitors can continue to do so. 1. Mudge S, Hayes D, Ellis D. Mayne Pharma International Pty Ltd, School of Molecular & Biomedical Science, University of Adelaide.
With Itragerm, patients are not subject to meal times, as it can even be administered on an empty stomach. Also, as it is a smaller capsule, it is easier to swallow. These characteristics can favour adherence to treatment and therefore have a favourable effect on its clinical efficacy. Furthermore, it is the only itraconazole compatible with antacids.
Itragerm 50 mg capsules are for oral administration and can be taken with or without food. One hard capsule of Itragerm 50 mg is equivalent to one hard capsule of conventional Itraconazole 100 mg. Therefore, the recommended dose of Itragerm is half the recommended dose of conventional Itraconazole hard capsules. The posology of Itragerm in adults for each indication is as follows:
The bioavailability of itraconazole can be reduced in some immunodepressed patients, e.g. with neutropenia, AIDS or transplants. Double the dose could be indicated.
References:: *Associated with lower absorption variability. 1. Midge S, Hayes D, Ellis D. Single-dose Phase 1 studies to evaluate the more predictable pharmacokinetics of SUBA®-itraconazole, a novel capsule formulation, relative to a conventional itraconazole capsule formulation [Poster]. Australian Society for infectious Disease; Adelaide, 2014.
The information provided on this website is intended for use by Health Care Professionals qualified to prescribe and supply medications in Spain, thus requiring specific scientific knowledge and training to interpret it correctly. If you are a Health Care professional click OK.